Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer-Reference-Cited by-同舟云学术

Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer

Published:2023-03 Issue: Volume:170 Page:282-289
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Jamieson Amy,Huvila Jutta,Leung Samuel,Chiu Derek,Thompson Emily F.,Lum Amy,Kinloch Mary,Helpman Limor,Salvador Shannon,Vicus Danielle,Kean Sarah,Samouelian Vanessa,Grondin Katherine,Irving Julie,Offman Saul,Parra-Herran Carlos,Lau Susie,Scott Stephanie,Plante Marie,McConechy Melissa K.,Huntsman David G.,Talhouk Aline,Kommoss Stefan,Gilks C. Blake,McAlpine Jessica N.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference23 articles.

1. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990–2019;Gu;Gynecol Oncol.,2021

2. ESGO / ESTRO / ESP guidelines for the management of patients with endometrial carcinoma;Concin;Int. J. Gynecol. Cancer,2020

3. Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma;Gilks;Am. J. Surg. Pathol.,2013

4. Interobserver variability in the diagnosis of uterine high-grade endometrioid carcinoma;Thomas;Arch Pathol Lab Med,2016

5. Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer;de Boer;Ann. Oncol.,2018

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ENGOT-en11/GOG-3053/KEYNOTE-B21: A Randomised, Double-Blind, Phase 3 Study of Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy in Patients With Newly Diagnosed, High-Risk Endometrial Cancer;Annals of Oncology;2024-09

2. Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment;International Journal of Molecular Sciences;2024-07-15

3. Is p53 immunohistochemistry alone useful for delineating adjuvant endometrial treatment in low-middle-income countries?;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-07

4. Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low‐ and high‐stage tumours;Histopathology;2024-06-11

5. Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials;The Lancet Oncology;2024-06